Abstract Anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis—the term recently applied to Wegener's granulomatosis—is a rare multi-system inflammation characterized by necrotizing granulomas and vasculitis. We investigated the ocular manifestations of this disease in a group of patients drawn from five inflammatory eye disease clinics across the United States. Of 8,562 persons with ocular inflammation, 59 individuals were diagnosed with ANCA-positive vasculitis; 35 males and 21 females, aged 16 to 96 years, were included in this study. Ocular diagnoses were scleritis (75.0%), uveitis (17.9%), and other ocular inflammatory conditions (33.9%) including peripheral ulcerative keratitis and orbital pseudotumor. Mean duration of ocular disease was 4.6 years. Oral corticosteroids and other systemic immunosuppressive agents were used by 85.7% and 78.5% of patients, respectively. Over time, patients with ANCA-positive vasculitis experienced 2.75-fold higher mortality than other patients with inflammatory eye disease.
vasculitis          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Vasculitis            

antibody                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Antibody              

vasculitis                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Vasculitis            

keratitis                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Keratitis             

vasculitis                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Vasculitis            

mortality                     0.748858101687952^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Mortality_rate        

scleritis                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Scleritis             

corticosteroids               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Corticosteroid        

United States                 0.9999656599081254^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/United_States         

Wegener                       0.6726206398921537^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Alfred_Wegener        

cytoplasmic                   0.9999999999987494^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cytoplasm             

immunosuppressive             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Immunosuppression     

inflammation                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Inflammation          

granulomas                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Granuloma             

inflammation                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Inflammation          

uveitis                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Uveitis               

